Authors:
HARTMANN JT
ALBERS P
CLEMM C
SOUCHON R
WEISSBACH L
BAMBERG M
BOKEMEYER C
Citation: Jt. Hartmann et al., REGISTER STUDY FOR THE TREATMENT OF BRAIN METASTASES OF MALIGNANT TESTICULAR-TUMORS, Onkologie, 21(3), 1998, pp. 262-263
Authors:
EIMERMACHER H
FRICK M
KALITSCHKE W
LINDEMANN HW
NITZ U
ADOMEIT A
SOUCHON R
SCHOLTEN T
Citation: H. Eimermacher et al., TOXICITY PROFILE OF TANDEM HIGH-DOSE CHEMOTHERAPY WITH EPIRUBICIN, CYCLOPHOSPHAMIDE AND THIOTEPA (ECT) AND STEM-CELL SUPPORT IN HIGH-RISK BREAST-CANCER, Bone marrow transplantation, 22, 1998, pp. 20-20
Authors:
HARTMANN JT
ALBERS P
CLEMM C
SOUCHON R
WEISSBACH L
BAMBERG M
BOKEMEYER C
Citation: Jt. Hartmann et al., REGISTER STUDY OF PATIENTS WITH CNS METASTASES FROM TESTICULAR GERM-CELL CANCER, Strahlentherapie und Onkologie, 174(6), 1998, pp. 339-339
Authors:
TAVAKKOLI J
CATHIGNOL D
SOUCHON R
SAPOZHNIKOV OA
Citation: J. Tavakkoli et al., MODELING OF PULSED FINITE-AMPLITUDE FOCUSED SOUND BEAMS IN TIME-DOMAIN, The Journal of the Acoustical Society of America, 104(4), 1998, pp. 2061-2072
Authors:
VONMINCKWITZ G
HEIDEMANN E
SOUCHON R
SAMONIGG H
HIRSCHMANN WD
BODENSTEIN H
SCHINDLER A
SCHULZE M
CLEMENS H
KONIG M
SCHARL A
FISCHER JT
KAUFMANN M
Citation: G. Vonminckwitz et al., MITOXANTRONE (N) VS. 5-FLUOROURACIL EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC)AS FIRST LINE THERAPY IN HIGH-RISK METASTATIC BREAST-CANCER/, European journal of cancer, 33, 1997, pp. 646-646
Authors:
HOFFMANN W
SCHIEBE M
HIRNLE P
SOUCHON R
CLEMENS M
ADAMIETZ I
BAMBERG M
Citation: W. Hoffmann et al., 13-CIS RETINOIC ACID AND INTERFERON-ALPHA PLUS OR MINUS IRRADIATION IN THE TREATMENT OF SQUAMOUS-CELL CARCINOMAS, International journal of cancer, 70(4), 1997, pp. 475-477
Authors:
PRAT F
CHAPELON JY
AREFIEV A
CATHIGNOL D
SOUCHON R
THEILLIERE Y
Citation: F. Prat et al., HIGH-INTENSITY FOCUSED ULTRASOUND TRANSDUCERS SUITABLE FOR ENDOSCOPY - FEASIBILITY STUDY IN RABBITS, Gastrointestinal endoscopy, 46(4), 1997, pp. 348-351
Authors:
GELET A
CHAPELON JY
BOUVIER R
SOUCHON R
PANGAUD C
ABDELRAHIM AF
CATHIGNOL D
DUBERNARD JM
Citation: A. Gelet et al., TREATMENT OF PROSTATE-CANCER WITH TRANSRECTAL FOCUSED ULTRASOUND - EARLY CLINICAL-EXPERIENCE, European urology, 29(2), 1996, pp. 174-183
Authors:
HOFFMANN W
HIRNLE P
CLEMENS M
SCHIEBE M
ADAMIETZ I
MOSE S
SOUCHON R
BAMBERG M
Citation: W. Hoffmann et al., 13-CIS RETINOIC ACID IN COMBINATION WITH INTEUFERON-ALPHA AND CONCOMITANT IRRADIATION IN SQUAMOUS-CELL CARCINOMAS - TOXICITY AND FEASIBILITY, Onkologie, 18(6), 1995, pp. 568-572
Authors:
BOKEMEYER C
SCHMOLL HJ
NATT F
KNOCHE M
BEYER J
SOUCHON R
Citation: C. Bokemeyer et al., PRELIMINARY-RESULTS OF A PHASE I II TRIAL OF PACLITAXEL IN PATIENTS WITH RELAPSED OR CISPLATIN-REFRACTORY TESTICULAR CANCER/, Journal of cancer research and clinical oncology, 120(12), 1994, pp. 754-757
Authors:
MARSCHNER N
KREIENBERG R
SOUCHON R
RATH U
EGGELING B
VOIGTMANN R
RUFFERT K
SCHUTTE M
AMMON A
KESZTYUS T
KAPLAN E
NAGEL G
Citation: N. Marschner et al., EVALUATION OF THE IMPORTANCE AND RELEVANCE OF DOSE INTENSITY USING EPIRUBICIN AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER - INTERIM ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL, Seminars in oncology, 21(1), 1994, pp. 10-16
Authors:
HEIDEMANN E
STEINKE B
HARTLAPP J
SCHUMACHER K
POSSINGER K
KUNZ S
NEESER E
VONINGERSLEBEN G
HOSSFELD D
CAFFIER H
SOUCHON R
WALDMANN R
BLUMNER E
CLARK J
Citation: E. Heidemann et al., PROGNOSTIC SUBGROUPS - THE KEY FACTOR FOR TREATMENT OUTCOME IN METASTATIC BREAST-CANCER - RESULTS OF A 3-ARM RANDOMIZED MULTICENTER TRIAL COMPARING DOXORUBICIN, EPIRUBICIN AND MITOXANTRONE EACH IN COMBINATION WITH CYCLOPHOSPHAMIDE, Onkologie, 16(5), 1993, pp. 344-353
Authors:
GELET A
CHAPELON JY
MARGONARI J
THEILLERE Y
GORRY F
SOUCHON R
BOUVIER R
Citation: A. Gelet et al., HIGH-INTENSITY FOCUSED ULTRASOUND EXPERIMENTATION ON HUMAN BENIGN PROSTATIC HYPERTROPHY, European urology, 23, 1993, pp. 44-47